Cerep’s Pharmacology and ADME-Tox platforms have been developed turning basic research into concrete
industrial applications. Cerep provides pharmacology and ADMET data to over 460 pharma and biotech companies worldwide.
The ever expanding range of assays is backed by industrial concepts: unvarying high quality, homogenous and robust data delivery,
low turnaround time and cost.
Cerep also provides customer-oriented-development services. With the “stand alone” assay development service,
clients can implement their specific assays developed exclusively or not. Customer-oriented-development services allow
clients to streamline assay development and screening thus gaining cost efficiency while maintening quality.